As colorectal cancer rates rise in patients under 50, at least two local health systems are hiring more doctors, realigning care and increasing education.
A new American Cancer Society study finds nearly half of all colorectal cancer cases now occur in adults under 65.
Rhythm Biosciences has reached a major milestone with the first commercial sale of its blood-based ColoSTAT colorectal cancer test, signalling the start of the company’s commercial clinical diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results